-
AO/PI Double Staining Kit: Practical Guide
2026-08-26
The AO/PI Double Staining Kit provides a rapid fluorescent cell staining workflow for separating viable, apoptotic, and necrotic cell populations in one sample. It is useful for endpoint cell viability assays and screening workflows, but it should not be used alone to confirm a specific apoptotic pathway or replace orthogonal validation.
-
Nonivamide: From TRPV1 Signaling to Translation
2026-08-26
Nonivamide, a capsaicin analog and TRPV1 agonist, offers translational researchers a way to connect tumor-cell apoptosis with peripheral neuroimmune signaling. This thought-leadership perspective outlines the evidence, experimental design principles, limitations, and strategic opportunities for oncology and inflammation research.
-
mCherry mRNA for Robust Fluorescent Assays
2026-08-25
EZ Cap™ mCherry mRNA combines Cap 1, 5mCTP, ψUTP, and an optimized poly(A) tail for consistent transient red fluorescence. This guide translates LNP-based mRNA delivery lessons into practical reporter workflows, with starting parameters and troubleshooting guidance for localization, uptake, and gene-editing assays.
-
β-Pseudouridine: Reading RNA Modification in saRNA
2026-08-25
β-Pseudouridine is examined here as a mechanistic RNA research reagent rather than a generic vaccine enhancer. Learn how its chemistry can be separated from self-amplifying RNA architecture when interpreting translational fidelity, RNA structure, and dose-sparing assays.
-
Chloroquine Diphosphate: Flux-Aware Assays
2026-08-24
Chloroquine Diphosphate is more than an autophagy inhibitor: it is a lysosome-perturbing probe that can expose hidden defects in autophagic flux. This guide connects its use in cancer research to LAMP1/LAMP2 biology and provides a more rigorous framework for interpreting autophagy assay results.
-
ISRIB (trans-isomer): PERK Inhibitor for Fibrosis
2026-08-24
A mechanism-first guide to using ISRIB (trans-isomer) to investigate the PERK–eIF2α–ATF4 axis, hepatic stellate-cell activation, ER stress-induced apoptosis, and translational opportunities in fibrosis and brain research.
-
DPPH Assay Design for Natural Product Decisions
2026-08-23
DPPH (2,2-Diphenyl-1-Picrylhydrazyl) enables rapid in vitro antioxidant screening, but its greatest value lies in disciplined interpretation. This guide connects assay chemistry, orthogonal validation, and the 2026 Taihangia rupestris study to improve natural product prioritization.
-
Neurotensin: GPCR Trafficking and miRNA Research
2026-08-22
Neurotensin is a 13-amino acid neuropeptide and Neurotensin receptor 1 activator for studying G protein-coupled receptor signaling. Product specifications support work on receptor recycling, miR-133α modulation, and miRNA regulation in gastrointestinal cells, while fluorescence-based spectral findings require separate validation.
-
Live-Dead Bacterial Staining Kit for Nanomaterial Studies
2026-08-22
Turn membrane damage into a rapid, imageable bacterial viability readout for nanoparticle, pH-response, and biofilm experiments. This workflow shows how the Live-Dead Bacterial Staining Kit complements CFU measurements while exposing treatment heterogeneity that bulk assays can miss.
-
VP39 Helix Reveals Baculovirus Assembly Principles
2026-08-21
Benning et al. use electron cryomicroscopy to resolve an infectious Autographa californica multiple nucleopolyhedrovirus nucleocapsid at 3.2 Å, showing how VP39 dimers form a 14-stranded helical tube. The structure identifies a conserved VP39 fold, a zinc finger domain, an intra-dimer sling, and closely related helical states that clarify the physical basis of baculovirus nucleocapsid assembly.
-
Hesperadin: Reframing Aurora B for Translation
2026-08-20
Hesperadin is more than a mitotic perturbation tool: it provides a mechanistic entry point for connecting Aurora B activity, chromosome surveillance, and translational questions in cancer research. This article integrates Hesperadin pharmacology with evidence that Plk1 regulates p31comet-dependent mitotic checkpoint complex disassembly, offering a practical framework for designing more informative cell-cycle studies.
-
Berberine Hydrochloride in Inflammation Workflows
2026-08-20
Berberine hydrochloride supports parallel studies of AMPK-driven metabolic regulation, LDL receptor expression, cancer-cell stress, and inflammatory signaling. This practical guide connects formulation and assay design with the oxidized self-DNA–NLRP3 findings from a recent acute kidney injury study, while clearly separating established evidence from exploratory use.
-
ATRNL1 and Cell-Specific Remodeling in Atrial Fibrillation
2026-08-19
A large-scale single-nucleus RNA-sequencing study of human left atrial tissue identifies cardiomyocyte- and macrophage-specific transcriptional changes associated with atrial fibrillation, with ATRNL1 emerging as a functional regulator of cellular stress responses and cardiac electrophysiology. The work connects population-level AF genetics with cell-resolved biology and provides a framework for prioritizing disease-relevant targets while clarifying the limits of transcriptomic and stem-cell-based validation.
-
Rapamycin (Sirolimus) and Intestinal Cell Fate
2026-08-19
Rapamycin (Sirolimus) offers a mechanistically defined way to interrogate how mTOR links epithelial polarity, YAP/TAZ activity, intestinal stem cell fate, and transit-amplifying cell expansion. This thought-leadership analysis translates findings from a CDC42–YAP–EGFR–mTOR study into experimental strategy, model selection, and translational decision-making.
-
Cell lysis buffer for WB and IP: CAF workflow
2026-08-18
Build a native protein workflow for testing CAF-driven signaling, ANGPTL4–IQGAP1 binding, and chemotherapy resistance. This guide connects inhibitor-rich lysis chemistry with Western blot, immunoprecipitation, co-IP, ELISA, and orthogonal validation while highlighting matrix-specific troubleshooting.